The Research, Development and Innovation Fund (RDIF) named its first cohort of 19 Second Level Fund Managers on 12 October 2026: 14 Alternative Investment Funds and 5 Focused Research Organisations, with Rs 7,131 crore committed
The Empowered Group of Secretaries cleared the cohort on 8 October 2026 and added five more technologies to the Fund's scope; the release names neither the managers nor the technologies
The managers will finance Eligible Technology Enterprises working at Technology Readiness Level 4 and above, and are expected to raise private capital equal to the RDIF money
The Technology Development Board signed an Rs 86 crore RDI Fund agreement with Bengaluru-based Peptris Technologies for VIGOR, which takes four AI-discovered drug candidates from TRL-4 to TRL-6
Draw private companies into R&D in sunrise and strategic sectors by offering long-tenor finance at low or nil interest
Key: Two tiers: ANRF's Special Purpose Fund finances SLFMs, which give loans or equity to firms. No grants. Sectors include energy security and transition, climate action, quantum, robotics, space, AI, biotechnology and pharma, and the digital economy
Start deployment before the open call concluded
Key: Approved by the EGoS on 12 January 2026 in the FRO category. TDB handles all RDI sectors; BIRAC handles biotechnology and allied fields. The 19 named in October 2026 are the first cohort from the open call
Facilitating one is among the objectives the Cabinet set for the RDI Scheme
Key: Fund of Funds is listed on the RDIF portal as an SLFM category alongside AIFs, DFIs, NBFCs and FROs
Peptris Technologies' programme to move AI-discovered molecules through preclinical and IND-enabling studies
Key: Candidates: PEPR111 (neuromuscular disorders, oncology), PEPRX101 (alopecia), PEPR202 (neuropathy), PEPR112 (DMD, Duchenne muscular dystrophy)
Statutory apex research funder that houses the RDI Fund. Its Governing Board gives the scheme strategic direction; its Executive Council, chaired by the Principal Scientific Adviser, recommends SLFMs. It replaced the Science and Engineering Research Board
Final approval of SLFMs, of sectors and technologies, and of changes to the scheme; reviews performance
Statutory body under DST, constituted on 1 September 1996. Finances commercialisation of indigenous technology from the Fund for Technology Development and Application
Not-for-profit Section 8, Schedule B public sector enterprise of the Department of Biotechnology; industry-academia interface for biotech firms
Created ANRF; in force from 5 February 2024. Repealed the Science and Engineering Research Board Act, 2008
Created TDB and the Fund for Technology Development and Application
AIFs are privately pooled funds registered with SEBI. Category I: venture capital, SME, social venture and infrastructure funds. Category II: private equity and debt funds. Category III: hedge funds, which may use leverage
A nine-step scale, first used by NASA, for how mature a technology is: TRL 1 is basic principles observed, TRL 9 is proven in real operation. RDIF reads TRL 4 as a laboratory-level prototype achieved, so basic and applied research stay outside the Fund.
| Aspect | Alternative Investment Fund | Focused Research Organisation |
|---|---|---|
| What it is | Privately pooled investment vehicle registered with SEBI | Statutory body, public institution or government-funded research or non-profit body with a technology focus |
| In the first cohort | 14 | 5 |
| How RDIF money arrives | Contribution to the fund | Loan |
| Earlier examples | None before this cohort | TDB and BIRAC (January 2026) |
GS Paper 3 > Science and Technology > Indigenisation of Technology; Economy > Investment Models
General Awareness > Financial Awareness > SEBI and Alternative Investment Funds
General Awareness > Government Schemes > Science and Technology
With reference to investments, consider the following: I. Bonds II. Hedge Funds III. Stocks IV. Venture Capital How many of the above are treated as Alternative Investment Funds?
Answer: Only two
An AIF, DFI, NBFC or Focused Research Organisation that receives RDIF money and passes it to companies as loans or equity
A company doing research, development and innovation at TRL 4 or above in an RDIF priority sector
A loan the lender may convert into the borrower's shares instead of taking repayment
Long-tenor money that accepts a slow, uncertain return, which deep-technology R&D needs